Author response for 'The efficacy and safety of Epstein‐Barr virus specific antigen peptide‐activated cytotoxic T cells treatment for refractory or recurrent angioimmunoblastic T cell lymphoma: A prospective clinical observational study'
Autor: | null Wang Bingjie, null Wang Lihong, null Shi Yongjin, null Liu Huihui, null Ou Jinping, null Cen Xi'nan |
---|---|
Rok vydání: | 2020 |
Databáze: | OpenAIRE |
Externí odkaz: |